Archive for the ‘Inflammation’ Category

The Daily Pills That Stop Cancer

https://justusrhope.substack.com/p/the-daily-pills-that-stop-cancer

The Daily Pills that Stop Cancer

AI Refines the Root Detox™ Protocol

Justus R. Hope

Apr 02, 2025

∙ Paid

Revised Protocol Risk Reductions

Thursday Dr. Paul E. Marik and I announced an all-supplement daily cocktail that reduced cancer risk by some 60%. We improved on this with Metformin, Ivermectin, and Mebendazole to reduce risk to the 70 to 80% range.

Today we announce revisions accomplished over the past few days with the assistance of AI.

Without this time-saving help, these revisions would have taken months. But we do not have months to spare as the world is dealing with an unprecedented uptick in cancers. Everyone needs this information now.

We will begin at the beginning, starting with our first 3-Supplement AI search on Cancer Risk that established the baseline. We will end with the 90 to 95 percent Optimal Cancer Risk Reduction Protocol, that we display above and once again, with analysis, at the conclusion. (See link for article)

________________

**Comment**

I learned something new. (Well, to be fair I’m always learning something new!)

I learned that it’s important to take enteric capsules of berberine, for the same reasons your proteolytic enzymes need to be enteric: to protect the supplement from stomach acid, allowing it to be dissolved in the intestines to enhance absorption and effectiveness. Berberine also outperformed Metformin.

Users in berberine clinical literature consistently report effects on energy metabolism and AMPK activation beginning to appear at the 6-8 weeks mark with consistent daily use. The most significant observations typically occur in the 6-12 week window. Source

Enter the Root6™ OTC Protocol:

Root6™ is nothing more than our basic four + Berberine and Sulforaphane. But because of synergy, the Cancer Risk Reduction is magnified, which is why cocktails of repurposed drugs work so well against cancer (very similar to how effectively they work against HIV compared with monotherapy).

Keep in mind the Root6™ is all OTC. Source

Category:

Cancer, diet and nutrition, Herbs, Inflammation, research, Supplements, Treatment

After These Young People Died, Postmortems Found an Unnerving Parasite Link

After These Young People Died, Postmortems Found an Unnerving Parasite Link

04 September 2026

ByEsra Öz

After These Young People Died, Postmortems Found an Unnerving Parasite Link (Breitschwerdt et al., Parasites & Vectors, 2026, CC BY 4.0.)

He had been athletic and healthy. Then came years of exhaustion, pain, memory problems, and psychiatric symptoms. Eventually, he had to leave college.

By the time the 27-year-old died, six years of illness and specialist care had failed to restore his health.

Tests performed after his death revealed DNA from two species of Babesia, tiny parasites that infect red blood cells, and Bartonella henselae, the bacterium that causes cat-scratch disease.

His was one of six cases in a postmortem investigation driven by families still seeking answers about their children’s illnesses.

Researchers confirmed DNA from one or both groups of microbes in five individuals.

The discovery left a crucial question unanswered: what role, if any, had these infections played in their illnesses?

The individuals were aged 14 to 30, and all had experienced chronic illness and suicidal thoughts or behaviors.

Four died by suicide, one through medical assistance in dying, and another from a severe disorder involving excessive immune activation.

Their parents contacted Edward Breitschwerdt, an infectious disease researcher at North Carolina State University, after learning about his team’s work on Bartonella and neurological illness. (See link for article)

_________________

**Comment**

This is the perfect article to follow up on the research on ‘PTLDS’ as it wonderfully shows how these pathogens are hard to find let alone effectively treat but are causing needless suicides and unbelievable suffering, due to an old faulty dogma that refuses to go away.

Important excerpt:

“They supplied medical histories and arranged for postmortem samples to reach his laboratory. Some had already been tested or treated for these infections while alive. The investigation was therefore not the first indication of infection in every case. At the laboratory, the initial search returned no clear answers. The researchers analyzed 125 DNA extracts from blood, laboratory blood cultures, tissues, and other body fluids. Initial quantitative PCR screening, which searches for selected genetic sequences, was negative throughout. Digital PCR, which divides samples into many tiny reactions, then produced faint signals in some samples. None reached the study’s threshold for a positive result. Additional targeted tests and DNA sequencing, which reads genetic material to identify organisms, provided confirmation.”

These poor folks would have been ignored by most researchers after the PCR screening, but Bart guru, Dr. Ed Breitschwerdt, is no dummy and kept digging. Notice they did additional ‘targeted’ tests AND DNA sequencing. Mainstream research simply quits looking after using tests that are wrong nearly 90% of the time.

In response to the question of whether the DNA points to an active infection at the time of death, Breitschwerdt said that detecting a known pathogen’s DNA in clinical specimens is medically accepted as evidence of “active infection.

Yet – for some reason, this ‘medically accepted’ evidence does NOT hold true for Lyme/MSIDS. It’s the perfect quagmire with no end in sight.

While this was an ‘observational study’, not a prospective case-controlled study, Breitschwerdt states:

“I think the best interpretation is that infections with vector-borne pathogens that have evolved to induce persistent infections in animals and human patients are not a current diagnostic consideration in patients with chronic illnesses or neuropsychiatric symptoms.”

For more:

Category:

Babesia, Bartonella, Inflammation, Lyme, Psychological Aspects, research, Testing

The Hidden Drivers of Inflammatory Bowel Disease (Lyme Disease is One)

https://imahealth.substack.com/p/the-hidden-drivers-of-inflammatory? Video Here

The Hidden Drivers of Inflammatory Bowel Disease

Crohn’s and colitis are called genetic, autoimmune, and idiopathic. What if all three labels are wrong? A new paper tests each against current evidence.

Independent Medical Alliance

Aug 02, 2026

Host: Dr. JP Saleeby | Guest: Josh Dech

What if Crohn’s disease and ulcerative colitis are caused by more than genetics alone?

Dr. Yusuf “JP” Saleeby, IMA Senior Fellow in Functional and Integrative Medicine, and gut health specialist Josh Dech take a closer look at what may contribute to inflammatory bowel disease, also known as IBD. The two recently co-authored a new paper published in the Journal of Independent Medicine. Their conversation traces how genetics, diet, gut health, and the environment may work together to shape both diseases.

Inflammatory bowel disease affects more than 7 million people worldwide and ranks among the fastest-growing chronic diseases globally. Nearly everyone diagnosed with Crohn’s disease or ulcerative colitis hears some version of the same three things: the disease is genetic, the immune system is attacking its own tissue, and the underlying cause is unknown. Those three explanations leave two treatments on the table, drugs and surgery, and they leave a patient nothing to investigate.

A new paper in the Journal of Independent Medicine argues that all three explanations fail against current evidence. Josh Dech and Dr. JP Saleeby, its co-authors, point out that each has been contested separately in the literature for two decades without anyone testing them as a set. Taken together, they conclude, the conventional model does not hold.

What replaces it is a disease that is partially heritable, environmentally activated, and immune-mediated, and the distinction is not academic for anyone living with one. If exposures determine whether susceptibility becomes disease, exposures can be found and changed. (See link for article, research paper and video)

_____________

SUMMARY:

  • The authors found that genetics only explain about a quarter of disease risk for irritable bowel (IBD).
  • The authors argue that the autoimmune label, despite holding for decades, is based on the weakest evidence and that pathogenic transfer has never been demonstrated.
  • The serologic markers long cited as evidence for autoimmunity turn out to recognize microbial and fungal targets but are not autoantibodies in the classical sense.
  • A review of 53 meta-analyses across 71 risk factors shows the following exposures for IBD that are quantified and modifiable:
    • antibiotic exposure
    • oral contraceptives
    • breast-feeding was protective for Crohn’s and colitis
    • ultra-processed food
    • air pollution
    • psychological stress
    • mold
    • mycotoxins
  • The authors state current treatments complement but ignore the environmental exposures.
  • The authors give the following issues that should be questioned alongside a standard work-up:
    • Birth mode and feeding history
    • Early antibiotic courses, particularly before age 5
    • Water damage & mold exposure at home, work and in vehicles.
    • Adolescent diet, stressors, and infections

At this point in the article, they described a case report on a 14 year old whose Crohn’s progressed far enough that surgeons planned to remove most of his intestines & place a colostomy. Testing pointed to chronic Lyme disease and three months into treatment a repeated scope test found no lesions.

In short, they conclude the following answers for IBS: antibiotic stewardship, breastfeeding support, reducing ultra-processed food, and remediating indoor mold.

After reading the comments after the article, I would be remiss if I did not mention the ‘vaccine’ issue due to the fact they all introduce foreign substances the body recognizes as foe, priming it for later potential problems such as life-threatening allergies to many things including food, which many are also linking to Alpha Gal Syndrome (AGS), an allergy to animal products supposedly caused by ticks – with no solid proof, as well as the fact some get AGS without any known tick involvement. So while ticks play a part, they are obviously not the only ingredient required to get AGS.

Pathogenic priming was shown clearly with the COVID gene therapy injections.

For more:

Category:

Candida, diet and nutrition, Inflammation, Lyme, research, Treatment

Self-Reported Observations of Unusual White Fibrous Structures in Embalmed Corpses: Multi-Year Survey Results

https://ijirms.in/index.php/ijirms/article/view/2201

Self-Reported Observations of Unusual White Fibrous Structures in Embalmed Corpses: Multi-Year Survey Results from Embalmers in Five Countries, 2022–2025

Thomas F. Haviland*·Laura Kasner·Daniel SantiagoiD

DOI:10.23958/ijirms/vol11-i07/2201· Pages: 204 – 208· Vol. 11, No. 07, (2026)· Published: July 1, 2026

PDFCitationShare

Views: 22,752 PDF downloads: 6,044

Abstract

Background: Beginning in 2020–2021, embalmers in multiple countries reported observing large, tough, rubbery white or off-white fibrous structures in the veins and arteries of embalmed corpses, which they described as distinct from classic postmortem clots.

Methods: We conducted four annual cross-sectional surveys (2022–2025) of active embalmers in the United States, Canada, United Kingdom, Australia, and New Zealand using SurveyMonkey. A dual distribution strategy (professional associations and direct emails to funeral homes) was used. Core questions assessed observation of unusual white fibrous structures and estimated percentage of corpses affected.

Results: Across 808 total responses, the proportion of embalmers reporting observation of these structures ranged from 66% to 83%. Weighted average prevalence in affected corpses ranged from 19% to 27%. The 2022 survey showed a marked increase in first observations beginning in 2020 and accelerating in 2021.

Conclusions: Multiple years of surveys document consistent self-reported observations by experienced embalmers of unusual white fibrous structures in a substantial fraction of corpses, with a clear increase noted around 2020–2021. These findings constitute a potential safety signal that warrants independent investigation by forensic pathologists and biomedical researchers to characterize the structures and determine their etiology.

(Click on top link for full article and pictures)

New White Fibrous Clots Publication

Dr. John Campbell

July 23, 2026

________________

**Comment**

For the ‘science’ skeptics out there, this is what research looks like when no ‘external’ funding or grants are received. Hence the use of SurveyMonkey.

Researchers know that when they study a topic that doesn’t fit the narrative, they are entirely on their own. No large NIH grants should be expected because our government is completely in bed with Big Pharma, who literally couldn’t care less if you live or die.

Lymeland has been in this lovely parallel universe for nigh on 40 years. Any research that moves the needle forward at all is independently funded and since research has become so incredibly expensive, cheap tools like SurveyMonkey are utilized.

In the case of Lyme/MSIDS, it is often called “Big Data,’ and relies on patient surveys. If you haven’t done it already, make sure to fill out the MyLymeData Project which allows patients to pool their health information through a secure website. “Big data” projects use advanced technology to gather and analyze huge amounts of patient data, which can assist researchers in studying disease patterns and answering important questions such as why do some people recover from Lyme disease, while others remain ill?

For more on the clots found in the COVID injected:

Category:

Activism, Heart Issues, Inflammation, research, vaccines

Autism Affects 1 in 31: One Doctor’s Search for Answers

https://imahealth.substack.com/p/autism-affects-1-in-31-one-doctors?

Autism Affects 1 in 31: One Doctor’s Search for Answers

Dr. Elizabeth Mumper’s 46-year pediatric career, spanning 600+ patients across 20 states, reveals what medical schools still aren’t teaching about autism.
Independent Medical Alliance
Apr 10, 2026

In 1979, a medical student at the Medical College of Virginia was told to make sure she saw the patient with autism at the children’s treatment center. At the time, the condition was so rare it might be the only case she’d encounter in her entire career. Prevalence was 1 in 5,000.

That student was Elizabeth Mumper. Over the next 46 years, she diagnosed and treated more than 600 children with autism from 20 different states and lectured on their medical conditions in 21 countries. Today she is a Senior Fellow at the Independent Medical Alliance. And autism prevalence has reached 1 in 31 children.

In a new article published in the Journal of Independent Medicine, Dr. Mumper traces what changed and what the medical establishment has been slow to recognize: that autism is not just a psychiatric diagnosis. Children with autism often have treatable medical conditions, including gut inflammation, immune dysregulation, metabolic abnormalities, and mitochondrial dysfunction. When those conditions are identified and addressed, the improvements can be dramatic. Some children no longer meet the diagnostic criteria at all.

“When you find a problem that is treatable, it’s very, very rewarding to see the children feel better, and the families are very grateful.” — Elizabeth Mumper

The gap between published research and clinical training, Dr. Mumper writes, remains wide. Most pediatric residents still learn the behavioral model. Her article lays out the medical comorbidities, the evidence behind targeted interventions, and the opportunity for clinicians willing to look deeper.

📖 Read and Download the Full Paper

How Autism Changed Throughout My Career (JIM Vol. 2, No. 2, 2026)
Author: Elizabeth Mumper

👉 Visit the Journal of Independent Medicine to create a free account and download the full article.

Related Reading

For more:

Category:

Autism, Inflammation, Lyme, Psychological Aspects, vaccines